News for Stereotaxis, Inc. (STXS)

Release Date: May 12, 2025For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Stereotaxis Inc (

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NSTXS.A - Stereotaxis IncQ1 2025 Stereotaxis Inc Earnings CallMay 12, 2025 / 08:30PM GMT ======

Stereotaxis (STXS) sees a promising 9% revenue boost in Q1 2025, driven by strategic product launches. Analysts set a positive one-year price target wit

The following slide deck was published by Stereotaxis, Inc.

Stereotaxis, Inc. (NYSE:STXS) Q1 2025 Earnings Conference Call May 12, 2025 4:30 PM ETCompany ParticipantsDavid Fischel - Chairman and CEOKim Peery - Chief...

In the first quarter, Stereotaxis (STXS) achieved revenue of $7.47 million, surpassing market expectations of $6.88 million. The company is focusing on strong c

Stereotaxis (STXS) delivered earnings and revenue surprises of 0% and 6.74%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Stereotaxis Inc (STXS) is set to release its Q1 2025 earnings on May 12, 2025. The consensus estimate for Q1 2025 revenue is $6.88 million, and the earnings are

Stereotaxis (STXS) is gearing up to present a live demonstration of its groundbreaking GenesisX Robotic System during the upcoming Heart Rhythm Symposium (HRS)

Fourth Quarter Revenue: $6.3 million, a 39% increase year-over-year.System Revenue (Q4 2024): $1.4 million, up from $0.1 million in Q4 2023.Recurring Revenue (

Mar 03, 2025 / 01:30PM GMTOperator Good morning. Thank you for joining us for Stereotaxis fourth-quarter and full-year 2024 earnings conference call. Certain st

Stereotaxis, Inc. (NYSE:STXS) Q4 2024 - Earnings Conference Call March 3, 2025 8:30 AM ETCompany ParticipantsDavid Fischel - Chairman and CEOKimberly Peery...

Stereotaxis (STXS) delivered earnings and revenue surprises of -80% and 9.43%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Revenue: $6.3 million for Q4 2024, slightly below the estimated $6.43 million, but marking a 39% increase year-over-year.Earnings Per Share (EPS): Reported at

**media[555336]**

Stereotaxis Inc (STXS) is set to release its Q4 2024 earnings on Mar 3, 2025. The consensus estimate for Q4 2024 revenue is $6.43 million, and the earnings are

The robotics industry, which has grown modestly over the past few years, has suddenly picked up pace after the emergence of AI.

Stereotaxis, Inc. (STXS) experienced a notable stock increase of 6.16%, reaching $2.33 per share with a trading volume of 280,309 shares. Despite a net loss of

Harvard Bioscience (HBIO) shares dropped 5.13%, trading at $2.13 with a volume of 73,085 shares. The turnover rate stood at 0.17%, and the stock experienced a 7